-
Alaska becomes 11th state to restrict DXM sales to adults
JUNEAU, Alaska - Alaska recently became the 11th state to help prevent the growing abuse threat posed by products containing dextromethorphan by restricting the sale of products containing DXM to Alaskans over the age of 18, or under 18 with a licensed practitioner’s prescription.
Perrigo announces FDA approval of store brand equivalent to Flonase
DUBLIN - The national brand equivalent of GlaxoSmithKline's Flonase will soon be shipping to store shelves with the announcement Monday that Perrigo and its partner West-Ward Pharmaceuticals on Tuesday gained approval from the U.S. Food and Drug Administration.
"This product approval and launch demonstrates the power of Perrigo's OTC platform," stated John Hendrickson, Perrigo CEO. "Our team has made significant efforts to bring this important product to our customers and consumers in the U.S."
